Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Clinical testing of LP-310 expected to commence in mid-2024    Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, PA., May 31, 2024 — Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first […]

SS Innovations Engages BDO as its new Auditor

SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of […]

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

Hauppauge, NY, May 30, 2024 – AmpliTech Group, Inc.  (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, announced today that it received a notice from the […]

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer PITTSBURGH, Pa., May 29, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces an abstract publication at the 2024 American Society of Clinical Oncology (ASCO) annual […]

BioStem Technologies to Sponsor MRO Better Half Dash

POMPANO BEACH, Fla., May 29, 2024 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will sponsor the MRO Better Half Dash which will be held on May 29, 2024, from 4:00 PM – 9:00 PM at the Trackhouse Motorplex, 130 Motorplex Dr, […]

BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology

Live troop field tests mark the final phase in integrating GentleDry technology into military rations BEND, Ore., May 28, 2024 — BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, has completed a successful shelf-life test through a strategic collaboration with the U.S. Army Combat Capabilities Development […]

BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility

BEND, Ore., May 24, 2024 – BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the expansion of its agreement with EnWave Corporation (TSX-V: ENW | FSE: E4U). As part of this enhanced partnership, BranchOut has purchased its third large-scale EnWave dehydration machine. This addition […]

JP 3E Holdings, Inc. Enters Agreement to Acquire Majority Stake in Bloxcross, Inc.

NEW YORK, NY, May 23, 2024 — PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI), formerly known as Spooz, Inc., is excited to announce the signing of an agreement to acquire a majority ownership interest in Bloxcross, Inc. (“BLOX”). Bloxcross is a trailblazing digital assets innovation company, recognized for its groundbreaking platform that revolutionizes […]